Skip to main content

Table 4 Chi-square results: recurrent freebayes mutations expanded beyond tumor suppressors and oncogenes

From: Germline genetic biomarkers to stratify patients for personalized radiation treatment

  1. Patients in Group C experienced high toxicity for late dysphagia (CTCAE grade 2 +), while patients in Group D experienced a low toxicity for late dysphagia (CTCAE grade 0–1)